Cost-effectiveness of natalizumab in patients with Crohn's disease who have failed Anti-TNFα therapy

被引：0
|
作者：
Sands, Bruce
Wolf, Douglas
Panjabi, Sumeet
Niecko, Timothy
Hass, Steven
Lacey, Loretto
机构：
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, MGH Crohns & Colitis Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Atlanta Gastroenterol Associates, Atlanta, GA USA
[4] Elan Pharmaceut Inc, San Francisco, CA USA
[5] LLC, Niecko Hlth Econ, Escondido, CA USA
[6] Elan Pharmaceut Ltd, Pharmacoecon, Dublin, Ireland
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-01025
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1025
引用
收藏
页码：S401 / S402
页数：2
相关论文
共 50 条
  • [41] Comparative Effectiveness of Vedolizumab Versus Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
    Kappelman, Michael
    Lewis, James D.
    Zhang, Xian
    Lin, Feng-Chang
    Weisbein, Laura
    Chen, Wenli
    Burris, Jessica L.
    Dorand, Jennifer E.
    Parlett, Lauren E.
    Haynes, Kevin
    Nair, Vinit
    Kaul, Alan F.
    Dobes, Angela
    Long, Millie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S676 - S676
  • [42] Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's disease
    Desai, Alka A.
    Marks, Daniel J. B.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 695 - 699
  • [43] Anti-TNF Treatment in Crohn's Disease: Toward Tailored Therapy?
    D'Haens, Geert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1140 - 1141
  • [44] Practical Application of Anti-TNF Therapy for Luminal Crohn's Disease
    Kamm, Michael A.
    Ng, Siew C.
    De Cruz, Peter
    Allen, Patrick
    Hanauer, Stephen B.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (11) : 2366 - 2391
  • [45] Anti-TNF antibody therapy in Crohn's disease: the risk of a switch
    Ricart, Elena
    Ordas, Ingrid
    Panes, Julian
    GUT, 2012, 61 (02) : 169 - 170
  • [46] Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
    Marquez-Megias, Silvia
    Nalda-Molina, Ricardo
    Sanz-Valero, Javier
    Mas-Serrano, Patricio
    Diaz-Gonzalez, Marcos
    Candela-Boix, Maria Remedios
    Ramon-Lopez, Amelia
    PHARMACEUTICS, 2022, 14 (05)
  • [47] Anti-TNF therapy for Crohn's disease: A perspective (Infliximab is not the drug we have been waiting for)
    Shanahan, F
    INFLAMMATORY BOWEL DISEASES, 2000, 6 (02) : 137 - 139
  • [48] EARLY INITIATION OF ANTI-TNF THERAPY IS COST-SAVING COMPARED TO LATE INITIATION FOR PATIENTS WITH CROHN'S DISEASE
    Beilman, Candace L.
    Kirwin, Erin
    Ma, Christopher
    McCabe, Christopher
    Fedorak, Richard N.
    Halloran, Brendan P.
    GASTROENTEROLOGY, 2017, 152 (05) : S137 - S137
  • [49] Renal Cell Carcinoma in Fistulizing Crohn's Disease Patient Who Received Anti-TNF α Therapy
    Albishi, Abdullah Mohammed
    Chakik, Rafaat
    Bazeed, Mohammed
    CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2021, 2021
  • [50] ANTI-TNFα ANTIBODY VERSUS NON-ANTI-TNFα MOLECULAR AGENTS FOR ULCERATIVE COLITIS PATIENTS WHO FAILED INITIAL ANTI-TNFα THERAPY
    Kanayama, Kengo
    Kato, Jun
    Shiratori, Wataru
    Nagashima, Ariki
    Ohta, Yuki
    Taida, Takashi
    Saito, Keiko
    Goto, Chihiro
    Kurosugi, Akane
    Ishikawa, Tsubasa
    Kaneko, Tatsuya
    Akizue, Naoki
    Okimoto, Kenichiro
    Matsumura, Tomoaki
    Kato, Naoya
    GASTROENTEROLOGY, 2022, 162 (07) : S1098 - S1098
12345